These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3697346)

  • 1. Kinetics of 8-methoxypsoralen and 5-methoxypsoralen distribution in guinea pig serum, epidermis and ocular lens.
    Wamer W; Giles A; Kornhauser A
    Photodermatol; 1987 Oct; 4(5):236-9. PubMed ID: 3697346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in topical and systemic reactivity of psoralens: determinations of epidermal and serum levels.
    Kornhauser A; Wamer WG; Giles AL
    Natl Cancer Inst Monogr; 1984 Dec; 66():97-101. PubMed ID: 6531046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoralen phototoxicity: correlation with serum and epidermal 8-methoxypsoralen and 5-methoxypsoralen in the guinea pig.
    Kornhauser A; Wamer WG; Giles AL
    Science; 1982 Aug; 217(4561):733-5. PubMed ID: 7100920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-Methoxypsoralen levels in blood of vitiligo patients and in skin, ophthalmic fluids, and ocular tissues of the guinea pig.
    Chakrabarti SG; Halder RM; Johnson BA; Minus HR; Pradhan TK; Kenney JA
    J Invest Dermatol; 1986 Aug; 87(2):276-9. PubMed ID: 3734475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoralens percutaneous permeation across the human whole skin and the epidermis in respect to their polarity (in vitro study).
    Saïd A; Makki S; Muret P; Humbert P; Millet J
    J Dermatol Sci; 1997 Feb; 14(2):136-44. PubMed ID: 9039977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration of 3H-8-methoxypsoralen and its metabolites in the rat lens and eye after a single oral administration.
    Wulf HC; Andreasen MP
    Invest Ophthalmol Vis Sci; 1982 Jan; 22(1):32-6. PubMed ID: 7056622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible binding of 5- and 8-methoxypsoralen to human serum proteins (albumin) and to epidermis in vitro.
    Artuc M; Stuettgen G; Schalla W; Schaefer H; Gazith J
    Br J Dermatol; 1979 Dec; 101(6):669-77. PubMed ID: 534612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on 8-methoxypsoralen tolbutamide interactions in vitro and in vivo.
    Bevilacqua R; Baccichetti F; Gaion RM
    Farmaco; 1991 Apr; 46(4):579-92. PubMed ID: 1930554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin concentration of 8-methoxypsoralen, 5-methoxypsoralen and 4,5,8-trimethylpsoralen in guinea pigs.
    Park YK; Hann SK; Im S; Kim S
    J Dermatol Sci; 1993 Feb; 5(1):19-24. PubMed ID: 8485109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration kinetics of 8-methoxypsoralen after 8-methoxypsoralen bath procedure with and without UVA irradiation.
    Neumann NJ; Grosse OJ; Ruzicka T; Lehmann P
    Skin Pharmacol Appl Skin Physiol; 2001; 14(4):210-6. PubMed ID: 11464103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of 8-methoxypsoralen 2 hours after oral administration.
    Steiner I; Prey T; Gschnait F; Washüttl J; Greiter F
    Acta Derm Venereol; 1978; 58(2):185-8. PubMed ID: 76402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of serum levels for three oral 8-methoxypsoralen brands.
    Walther T; Quednow B; Haustein UF; Meyer FP
    Photodermatol Photoimmunol Photomed; 1992 Feb; 9(1):1-3. PubMed ID: 1390116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro kinetics of 8-methoxypsoralen penetration into human lymphoid cells.
    Karolak L; Tod M; Leon A; Heudes AM; Petitjean O; Laroche L
    Photodermatol Photoimmunol Photomed; 1992 Apr; 9(2):58-60. PubMed ID: 1489716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4'-Methyl derivatives of 5-MOP and 5-MOA: synthesis, photoreactivity, and photobiological activity.
    Gia O; Anselmo A; Conconi MT; Antonello C; Uriarte E; Caffieri S
    J Med Chem; 1996 Oct; 39(22):4489-96. PubMed ID: 8893844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites.
    Mays DC; Rogers SL; Guiler RC; Sharp DE; Hecht SG; Staubus AE; Gerber N
    J Pharmacol Exp Ther; 1986 Feb; 236(2):364-73. PubMed ID: 3944766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [8-methoxypsoralen serum content of problem patients in PUVA therapy].
    Walther T; Haustein UF
    Dermatol Monatsschr; 1990; 176(5-6):317-21. PubMed ID: 2227049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of [14C-5] 8-methoxypsoralen uptake by UVA irradiated and non-irradiated rabbit eye tissues.
    Malinin GI; Glew WB; Roberts WP; Nigra TP
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):223-34. PubMed ID: 7244361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacokinetic comparison in dogs of seven brands of 8-MOP and five new formulations.
    Van Boven M; Roelandts R; De Greef H; Kinget R; Adriaens P; Daenens P
    Photodermatol; 1985 Feb; 2(1):27-31. PubMed ID: 3982992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrofluorimetric determination of 5-methoxypsoralen pharmacokinetic in patients' serum.
    Saïd A; Makki S; Muret P; Toubin G; Humbert P; Millet J
    Exp Dermatol; 1997 Apr; 6(2):57-63. PubMed ID: 9209885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood.
    Shephard SE; Zogg M; Burg G; Panizzon RG
    Arch Dermatol Res; 1999 Sep; 291(9):491-9. PubMed ID: 10541879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.